Shareholding disclosure

ADDEX THERAPEUTICS LTD

Declared position

60.11%

Threshold

Crossed downwards

Timeline

Published

24.12.2021

Transaction

16.12.2021

Transfer date

21.12.2021

Voting rights breakdown

Voting rights acquired23.2%
Voting rights sold60.11%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TALCL000B8

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

Following Securities Purchase Agreement signed on December 16, 2021: - Crossing down of 25% share and purchase positions threshold. All remaining shares held in purchase position cannot be sold by Addex Therapeutics until March, 21 2022. - Crossing up of 33% and 50% sale position thresholds due to granting of warrants

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open